IFNc response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  del Corral, Helena ^a,b   París, Sara C ^a,b   Marín, Nancy D ^a   Marín, Diana M ^a,b   López, Lucelly ^a,b   Henao, Hanna M ^a,b   Martínez, Teresita ^a,b   Villa, Liliana ^a   Barrera, Luis F ^a,b   Ortiz, Blanca L ^a,b   Ramírez, María E ^a   Montes, Carlos J ^a   Oquendo, María C ^a,b   Arango, Lisandra M ^a,b   Riaño, Felipe ^a   Aguirre, Carlos ^a   Bustamante, Alberto ^a   Belisle, John T ^d   Dobos, Karen ^d   Mejía, Gloria I ^b,c   Giraldo, Margarita R ^e   Brennan, Patrick J ^d   Robledo, Jaime ^b,c   Arbeláez, María P ^a,b   Rojas, Carlos A ^a,b   García, Luis F ^a,b   more..

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b CCITB Centro Colombiano de Investigación en Tuberculosis   (Colombia)

^c Unidad de Biología Celular y Molecular   (Colombia)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e Direccion Seccional de Salud de Antioquia   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN; CULTURE FILTRATE PROTEIN 10; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; PROTEIN AG85A; PROTEIN HSPX; TUBERCULIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD CULTURE; CHILD; COHORT ANALYSIS; COLOMBIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DRUG CONTRAINDICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INFECTION RATE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS CONTROL; AGING; BIOSYNTHESIS; DEMOGRAPHY; FAMILY SIZE; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGING; ANTIGENS, BACTERIAL; COLOMBIA; DEMOGRAPHY; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INCIDENCE; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 76949092851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008257     Document Type: Article

References (53)

1. World Health Organization (2008) Global Tuberculosis Control:Surveillance, Planning, Financing:WHO Report 2008. Geneva, Switzerland: WHO.
2. Dye C, Hosseini M, Watt C (2007) Did we reach the 2005 targets for tuberculosis control? Bull World Health Organ 85: 364-369.
3. Maher D, Dye C, Floyd K, Pantoja A, Lonnroth K, et al. (2007) Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ 85: 341-347.
4. Morrison J, Pai M, Hopewell PC (2008) Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 8: 359-368.
5. Young DB, Perkins MD, Duncan K, Barry CE III (2008) Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 118: 1255-1265.
6. Styblo K (1980) Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 20: 1-63.
7. Flynn JL, Ernst JD (2000) Immune responses in tuberculosis. Curr Opin Immunol 12: 432-436.
8. Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, et al. (2003) The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100: 7877-7882.
9. Mostowy S, Cleto C, Sherman DR, Behr MA (2004) The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb) 84: 197-204.
10. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
11. Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 13: 175-182.
12. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40: 704-706.
13. Higuchi K, Harada N, Fukazawa K, Mori T (2008) Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis 88: 244-248.
14. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, et al. (2008) Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 3: e1379.
15. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A (2008) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177: 1164-1170.
16. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, et al. (2008) Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 149: 777-787.
17. Yuan Y, Crane DD, Simpson RM, Zhu Y, Hickey MJ, et al. (1998) The 16-kDa alpha -crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci 95: 9578-9583.
18. Young D, Dye C (2006) The development and impact of tuberculosis vaccines. Cell 124: 683-687.
19. DANE (2006) Censo General 2005 República de Colombia, Población Censada en Medellín y Area Metropolitana.
20. American Thoracic Society, CDC (1990) Diagnostic standards anc classification of tuberculosis. Am Rev Res Dis 142: 725-735.
21. Stop TB Partnership Childhood TB Subgroup World Health Organization (2006) Introduction and Diagnosis of tuberculosis in children. In: Guidance for National Tuberculosis Programmes on the Management of tuberculosis in children WHO.
22. Cardoso-Leao S, Martin A, Mejía GI, Palomino JC, Robledo J, et al. (2004) Practical Handbook for the phenotypic and genotypic identification of mycobacteria. Brussels, Belgium: INCO European Commission International Cooperation for Developing Countries Concerted Action.
23. Black GF, Weir RE, Chaguluka SD, Warndorff D, Crampin AC, et al. (2003) Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol 10: 602-611.
24. Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, et al. (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264: 95-108.
25. Johnson NL, Kotz S, Balakrishnan N (1994) Continuos Univariate Distributions. New York: Wiley.
26. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
27. Kleinbaum D, Klein M (2005) Logistic regression for correlated data. In: Logistic Regression: A self learning text. Atlanta: Springer. pp 327-375.
28. Ministerio de Salud de Colombia (2000) Guía de atención de la tuberculosis pulmonar y extrapulmonar. Normas técnicas y guias de atención. Resolución No 412.
29. World Health Organization (2008) Implementing the WHO Stop TB Strategy: A handbook for national tuberculosis programmes. Geneva, Switzerland.: World Health Organization. 198 p.
30. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-725.
31. Enarson DA, Rieder HL, Arnadottir T, Trebucq A (2000) Management of Tuberculosis A guide for low income countries. Paris, France: IUATLD.
32. American Thoracic Society, Centers for Disease Control (1999) Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. Am J Respir Crit Care Med. pp 221S-2247.
33. Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
34. Dillon DC, Alderson MR, Day CH, Bement T, Campos-Neto A, et al. (2000) Molecular and Immunological Characterization of Mycobacterium tuberculosis CFP-10, an Immunodiagnostic Antigen Missing in Mycobacterium bovis BCG. J Clin Microbiol 38: 3285-3290.
35. Launois P, DeLeys R, Niang MN, Drowart A, Andrien M, et al. (1994) T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 62: 3679-3687.
36. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, et al. (2008) T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 3: e1850.
37. Lewinsohn DA, Lewinsohn DM (2008) Immunologic susceptibility of young children to Mycobacterium tuberculosis. Pediatr Res 63: 115.
38. Soysal A, Turel O, Toprak D, Bakir M (2008) Comparison of positive tuberculin skin test with an interferon-gamma-based assay in unexposed children. Jpn J Infect Dis 61: 192-195.
39. Jackson-Sillah D, Hill PC, Fox A, Brookes RH, Donkor SA, et al. (2007) Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia. Trans R Soc Trop Med Hyg 101: 594-601.
40. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168-1173.
41. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192.
42. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, et al. (2005) Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366: 1443-1451.
43. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, et al. (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831-839.
44. Hussain R, Talat N, Shahid F, Dawood G (2007) Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clin Vaccine Immunol 14: 1578-1586.
45. Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, et al. (2008) Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS One 3: e3407.
46. Lalvani A, Richeldi L, Kunst H (2005) Interferon gamma assays for tuberculosis. Lancet Infect Dis 5: 322-324.
47. Connell TG, Rangaka MX, Curtis N, Wilkinson RJ (2006) QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev Mol Diagn 6: 663-677.
48. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM (2007) Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol 14: 796-798.
49. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, et al. (2007) Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 14: 880-885.
50. Adetifa IM, Brookes R, Lugos MD, de Jong BC, Antonio M, et al. (2007) Rising ELISPOT count prior to the onset of symptoms of full-blown tuberculosis disease. Int J Tuberc Lung Dis 11: 350-352.
51. Richeldi L, Ewer K, Losi M, Bergamini BM, Millington K, et al. (2007) T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 119: e1-e5.
52. Arend SM, Geluk A, Meijgaarden KEV, Dissel JTV, Theisen M, et al. (2000) Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and in mixtures of synthetic peptides. Infect Immun 68: 3314-3321.
53. Gray A (2001) Definitions of Crowding and the Effect of Crowding on Health: A Literature Review. Wellington, New Zealand: Ministry of Social Policy. 39 p.